Long-term results of Roux-en-Y gastric bypass (RYGB) versus single anastomosis duodeno-ileal bypass (SADI) as revisional procedures after failed sleeve gastrectomy: a systematic literature review and pooled analysis - Takeaways - MDSpire

Long-term results of Roux-en-Y gastric bypass (RYGB) versus single anastomosis duodeno-ileal bypass (SADI) as revisional procedures after failed sleeve gastrectomy: a systematic literature review and pooled analysis

  • By

  • Theodoros Thomopoulos

  • Styliani Mantziari

  • Gaëtan-Romain Joliat

  • November 23, 2024

  • 0 min

Share

  • 1

    Sleeve gastrectomy (SG) is the most common bariatric procedure but may lead to insufficient long-term weight loss in 20-50% of patients.

  • 2

    Revisional bariatric surgery (RBS) is often necessary after failed SG, with options including RYGB, Re-SG, and SADI.

  • 3

    RYGB is particularly indicated for patients with SG-related gastro-esophageal reflux disease (GERD), but 25% may still experience suboptimal weight loss.

  • 4

    SADI has gained popularity due to promising weight loss results and fewer complications compared to BPD/DS, but long-term data is limited.

  • 5

    This systematic review aims to compare the long-term outcomes of RYGB and SADI as RBS options after failed SG, with a follow-up of at least 5 years.

Original Source(s)

Long-term results of Roux-en-Y gastric bypass (RYGB) versus single anastomosis duodeno-ileal bypass (SADI) as revisional procedures after failed sleeve gastrectomy: a systematic literature review and pooled analysis

  • by Theodoros Thomopoulos, Styliani Mantziari, Gaëtan-Romain Joliat

  • November 23, 2024

Related Content

Global Trends and Research Topics in Gastric Bypass Clinical Trials: A Bibliometric Analysis and Latent Dirichlet Allocation (LDA) Study

A temporally Anchored Retrieval-Augmented Generation Framework for Metabolic and Bariatric Surgery Patient Education: An IFSO Artificial Intelligence Task Force Multinational Validation Study

Venous Thromboembolism and Bleeding Risk in a Population with Obesity Hospitalized for Surgery and Receiving Enoxaparin for Thromboprophylaxis